Method for screening CD47/SIRP alpha blocker by HTRF (Homogeneous Time Resolved Fluorescence) one-step method
A blocking agent and one-step technology, which is applied in the field of screening CD47/SIRPalpha blocking agents by using HTRF one-step method, can solve problems such as experimental error, time-consuming, unstable, etc., and avoid false positives and false negatives, and fluorescence duration Long-term, save the effect of experimental workload
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] 1) Prepare the protein. CD47 starts from 10nM and is diluted by 3 times to obtain different concentrations from 10nM to 0nM; SIRPalpha is diluted by 3 times from 11.1nM to obtain different concentrations from 11.1nM to 0nM.
[0032] 2) Add 5ul each of the prepared protein to the 384-well detection plate, incubate at room temperature for 15 minutes, add the tag antibody coupled to Donor and Acceptor (or add 10ul after mixing the same amount), and incubate for 1 hour to read. According to the principle of HTRF method, the fluorescence ratio of 665nm / 620nm is detected, and the protein binding is judged according to the ratio. The higher the signal, the more binding, the result is figure 2 .
Embodiment 2
[0034] 1) Configure the positive blocking agent, and dilute the mouse-derived anti-human CD47blocking antibody in a gradient, starting from 100nM, and dilute 3 times;
[0035] 2) Prepare the protein, and screen the blocking agent according to the appropriate protein concentration in Example 1. CD47 is 2nM and SIRPalpha is 1nM;
[0036] 3) The prepared blocking agent and protein are sequentially added to the 384-well detection plate. After 15 minutes of incubation at room temperature, add the tag antibody coupled to Donor and Acceptor (or add 10ul after mixing the same amount), and incubate for 1 hour to read.
[0037] According to the principle of HTRF method, the fluorescence ratio of 665nm / 620nm is detected, and the protein binding is judged according to the ratio. The higher the signal, the more binding, the result is image 3 .
[0038] by figure 2 with 3 It can be seen that the present invention is suitable for screening a variety of CD47 or SIRP alpha blockers, with a small amou...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com